The approved combination of Tixagevimab/Cilgavimab has been shown to decrease the rate of symptomatic SARS-CoV-2 infection in patients at increased risk of inadequate response to vaccination. However,

NIAID Data Ecosystem10

Additional file 6: of South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on Îą4Î˛7 for replication

HIV病毒变异分析

病毒复制机制

Characteristics of IECs used in this study.

Figshare2016-12-15 更新40

HIV Status, PrEP Use and Viral Suppression.

HIV监测

暴露前预防效果评估

BackgroundThe HIV Prevention Trials Network (HPTN) 096 study was designed to address the markedly higher rates of HIV incidence among Black men who have sex with men (MSM) in the Southern United State

Figshare2025-10-17 更新20

Human immunodeficiency virus 1 Targeted Locus (Loci). Human immunodeficiency virus 1

资源简介：

相关数据集